Flexible designs for pivotal clinical trials Vlad Dragalin, RSU-SDS-BDS-GSK FDA/Industry Workshop Session: Flexible Designs – Are We Ready Yet? Washington,
The Role of Biotechnology and Bioinformatics in FDAs Critical Path Initiative Janet Woodcock M.D. Deputy Commissioner/Chief Medical Officer US Food and.
THE ROLE OF ECVAM IN PROMOTING THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS Dr Andrew Worth European Centre for the Validation of Alternative Methods.
Regulatory Acceptance of Alternative Methods- Pharmaceuticals in the U.S. A. Jacobs 11/07 (not an official opinion)
Environmental Laboratory Accreditation Course for Radiochemistry Presented by Minnesota Department of Health Pennsylvania Department of Environmental Protection.
Army MMRP Site Inspections Performance-Based Contract Lessons Learned Gaby A. Atik, P.E. [email protected] FPM group August 2007.
MSW Conversion Technologies: Status in Summer 2012 Presented to the Board of Directors of the Municipal Review Committee, Inc. August 1, 2012.
ConSoil 2008 Data Management
Dragalin Flexible Design
Institute of Clinical Research
National Facility for Tribal and Herbal Medicine, Institute of Medical Sciences, Banaras Hindu University
2013 Avoca Industry Survey Executive Summary